IRIS
MALCOVATI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.547
AS - Asia 6.237
EU - Europa 4.023
SA - Sud America 1.017
Continente sconosciuto - Info sul continente non disponibili 508
AF - Africa 192
OC - Oceania 18
Totale 20.542
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.303
CN - Cina 2.697
SG - Singapore 1.431
HK - Hong Kong 881
IE - Irlanda 870
BR - Brasile 785
VN - Vietnam 565
IT - Italia 459
RU - Federazione Russa 446
UA - Ucraina 439
FI - Finlandia 428
DE - Germania 422
FR - Francia 283
GB - Regno Unito 215
SE - Svezia 194
IN - India 127
CA - Canada 106
BD - Bangladesh 88
AR - Argentina 77
MX - Messico 69
ZA - Sudafrica 67
JP - Giappone 64
IQ - Iraq 55
NL - Olanda 53
TR - Turchia 47
AT - Austria 42
PK - Pakistan 33
PL - Polonia 33
ES - Italia 32
EC - Ecuador 31
VE - Venezuela 31
CO - Colombia 30
ID - Indonesia 28
UZ - Uzbekistan 25
BE - Belgio 24
SA - Arabia Saudita 24
KE - Kenya 20
CL - Cile 18
PH - Filippine 18
TN - Tunisia 18
IL - Israele 17
PY - Paraguay 17
CR - Costa Rica 16
AU - Australia 14
MY - Malesia 14
JO - Giordania 13
MA - Marocco 13
PE - Perù 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
CZ - Repubblica Ceca 11
KR - Corea 11
EU - Europa 10
LT - Lituania 10
DZ - Algeria 9
EG - Egitto 9
NP - Nepal 9
MU - Mauritius 8
NG - Nigeria 8
BO - Bolivia 7
CH - Svizzera 7
ET - Etiopia 7
GT - Guatemala 7
HN - Honduras 7
JM - Giamaica 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
AL - Albania 6
NI - Nicaragua 6
PS - Palestinian Territory 6
RS - Serbia 6
AO - Angola 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
IR - Iran 5
PA - Panama 5
RO - Romania 5
UY - Uruguay 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
GR - Grecia 4
HU - Ungheria 4
LV - Lettonia 4
SN - Senegal 4
SV - El Salvador 4
XK - ???statistics.table.value.countryCode.XK??? 4
GD - Grenada 3
GH - Ghana 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BW - Botswana 2
CU - Cuba 2
CY - Cipro 2
GE - Georgia 2
Totale 19.998
Salva come PNG Salva come JPEG
Città #
San Jose 970
Chandler 911
Hong Kong 871
Dublin 868
Ashburn 760
Singapore 732
Dallas 596
Jacksonville 584
Nanjing 524
Beijing 390
Boardman 379
Council Bluffs 326
Lauterbourg 211
Princeton 210
Ho Chi Minh City 200
Nanchang 197
Lawrence 196
Los Angeles 193
Medford 187
New York 174
Wilmington 172
Changsha 154
Hebei 145
Shenyang 138
Hanoi 136
Jiaxing 119
Buffalo 117
Helsinki 115
Milan 102
Redondo Beach 90
Tianjin 89
Santa Clara 86
Ann Arbor 84
Hangzhou 80
Shanghai 78
Moscow 77
Munich 72
São Paulo 67
Pavia 66
The Dalles 60
Seattle 54
Columbus 53
Tokyo 53
Nuremberg 49
Orem 46
Chicago 40
Johannesburg 38
Woodbridge 38
San Francisco 37
Frankfurt am Main 36
Toronto 36
Norwalk 35
Turku 35
Washington 33
Brooklyn 32
Warsaw 32
Belo Horizonte 30
Haiphong 30
Montreal 29
Da Nang 28
Chennai 27
Denver 27
Brussels 24
London 24
Mexico City 24
Fairfield 22
Guangzhou 22
Verona 21
Atlanta 20
Jinan 20
Nairobi 20
Tashkent 20
Amsterdam 19
Rio de Janeiro 19
Boston 18
Zhengzhou 18
Falls Church 17
Phoenix 17
Baghdad 16
Brasília 16
Poplar 16
Des Moines 15
Houston 15
Rome 15
Stockholm 15
Ankara 14
Bogotá 14
Kunming 14
Vienna 14
Istanbul 13
Amman 12
Charlotte 12
Falkenstein 12
San José 12
Baku 11
Dearborn 11
Dhaka 11
Guayaquil 11
Hải Dương 11
Manchester 11
Totale 12.960
Salva come PNG Salva come JPEG
Nome #
A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data 174
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 164
A rule-based expert system for automatic implementation of somatic variant clinical interpretation guidelines 153
ANALYSIS OF THE MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 151
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 148
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 147
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 146
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes 145
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 145
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia 144
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms 144
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts 137
Circulating endothelial cell separation from peripheral blood of patients affected by myelodysplastic syndromes: Preliminary results obtained by a new immunomagnetic procedure 132
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 131
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. 131
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 130
Classification and prognostic evaluation of myelodysplastic syndromes 128
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 126
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome 124
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. 123
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 122
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. 121
Clinical significance of somatic mutation in unexplained blood cytopenia 120
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 119
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes 117
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 116
Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010. 115
CHARACTERIZATION OF A CELLULAR MODEL FOR THE STUDY OF MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 114
Clinical and biological implications of driver mutations in myelodysplastic syndromes 112
Revised international prognostic scoring system for myelodysplastic syndromes 112
Hematologic passport for athletes competing in endurance sports: a feasibility study. 111
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. 111
Pan-cancer analysis of whole genomes 111
Myelodysplastic syndromes: diagnosis and staging. 110
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools. 110
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System. 109
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 108
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 108
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 108
Relationship between clone metrics and clinical outcome in clonal cytopenia 107
Myelodysplastic syndromes--coping with ineffective hematopoiesis. 107
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 107
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. 107
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 105
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. 105
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications 105
Somatic mutations of calreticulin in myeloproliferative neoplasms 105
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. 104
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 104
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 103
Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations 103
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome 101
Myelodysplastic/myeloproliferative disorders 101
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 101
VASCULAR ENDOTHELIAL GROWTH FACTOR OVEREXPRESSION IN BONE MARROW CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME: BIOLOGICAL AND CLINICAL RELEVANCE 101
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. 101
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome 100
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors. 100
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. 100
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms 100
Appreci8: A pipeline for precise variant calling integrating 8 tools 100
ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing 99
Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives 99
Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes 99
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. 97
Atomic-Level Mechanism of Pre-mRNA Splicing in Health and Disease 97
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia 97
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts 96
Clinical significance of genetic aberrations in secondary acute myeloid leukemia. 95
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome 95
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications 95
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 95
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes 94
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 93
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 92
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications 92
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms 92
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 92
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes 91
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging. 91
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 91
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. 90
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 90
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. 90
Myelodysplastic/myeloproliferative neoplasms 89
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. 89
THE IMPACT OF THE DEGREE OF ANEMIA ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME. A BASIS FOR PROGNOSTIC ASSESSMENT AND CLINICAL DECISION MAKING 89
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. 88
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. 88
Genetic and clinical heterogeneity of ferroportin disease. 88
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes 88
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) 87
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. 87
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective 87
Splenectomy for treatment of immune thrombocytopenic purpura. 86
Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes. 86
Myelodysplastic syndromes with bone marrow fibrosis. 86
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group 86
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS 86
Simian virus 40 and lymphoproliferative disorder. 85
Totale 10.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022902 0 4 15 15 34 34 12 42 57 34 143 512
2022/20232.553 272 138 20 234 248 264 2 165 1.050 25 96 39
2023/20241.160 85 199 58 78 113 327 29 69 10 23 78 91
2024/20253.174 75 286 106 84 72 195 203 228 653 170 366 736
2025/20268.000 544 693 909 919 866 320 1.612 343 644 610 325 215
2026/2027658 191 467 0 0 0 0 0 0 0 0 0 0
Totale 20.542